Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO …
I Gentile, A Giaccone, MM Scirocco, F Di Brizzi… - medRxiv, 2024 - medrxiv.org
Introduction Ritonavir-boosted nirmatrelvir (N/r) is an antiviral which targets the main viral
protease, administered to prevent the progression of SARS-CoV-2 infection in patients at …
protease, administered to prevent the progression of SARS-CoV-2 infection in patients at …
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO …
I Gentile, A Giaccone, MM Scirocco, F Di Brizzi… - 2024 - europepmc.org
Ritonavir-boosted nirmatrelvir (N/r) is an antiviral which targets the main viral protease,
administered to prevent the progression of SARS-CoV-2 infection in patients at high risk for …
administered to prevent the progression of SARS-CoV-2 infection in patients at high risk for …